2023-04-24 09:29:36 ET
- Cannara Biotech press release ( OTCQB:LOVFF ): Q2 GAAP EPS of -$0.01.
- Revenue of $13M (+79.8% Y/Y).
For further details see:
Cannara Biotech GAAP EPS of -$0.01, revenue of $13Mhome / stock / lovff / lovff news
2023-04-24 09:29:36 ET
For further details see:
Cannara Biotech GAAP EPS of -$0.01, revenue of $13MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Inc Company Name:
LOVFF Stock Symbol:
Market:
Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0) announced its fiscal second quarter 2024 financial and operating results for the three a...
Cannara Biotech Reports Q2 2024 Financial Results Canada NewsWire Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4...
--News Direct-- Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square fee...